Search for: "Pfizer Manufacturing Holdings LLC"
Results 61 - 65
of 65
Sort by Relevance
|
Sort by Date
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in… [read post]
15 Mar 2008, 7:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WIPO Copyright Committee 16th session to discuss Broadcast Treaty, new proposal for exceptions and limitations agreement: (Public Knowledge), (Public Knowledge), (Intellectual Property Watch), (Public Knowledge), (Public Knowledge), (IPwar’s), (Intellectual Property Watch), (KEI), (Public Knowledge), (IP Justice), (IP Justice), (KEI), (KEI),… [read post]
29 Feb 2008, 8:00 am
: (creativecommons.org)Pharma & BiotechPharma & Biotech - GeneralScience Commons news: A commons-sense approach to winning the drug discovery lottery: (creativecommons.org),India: Hindu Business Line reports on why pharma companies are pushing for tax incentives: (Spicy IP), India: J Mitra gets injunction against Span Diagnostics in patent dispute before Delhi High Court over device used in detection of Hep C: (Generic Pharmaceuticals & IP), India: Patent Office releases… [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners:… [read post]
11 Jan 2008, 9:00 am
., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v Sandoz that use of Markush group language in the specification does not necessarily limit construction of claim terms: (Chicago IP Litigation),Coreg / Dilatrend / Eucardic (Carvedilol) - Teva Pharmaceutical… [read post]
